Safety and Efficacy in the Transcortical and Transsylvian Approach in Insular High-Grade Gliomas: A Comparative Series of 58 Patients
Current Oncology,
Journal Year:
2025,
Volume and Issue:
32(2), P. 98 - 98
Published: Feb. 10, 2025
Gliomas
within
the
insular
region
represent
one
of
most
challenging
problems
in
neurosurgical
oncology.
There
are
two
main
surgical
approaches
to
address
complex
vascular
network
and
functional
areas
around
insula:
transsylvian
approach
transcortical
approach.
In
literature,
there
is
not
a
clear
consensus
on
best
terms
safety
efficacy.
The
purpose
this
study
evaluate
effectiveness
these
analyze
prognostic
factors
natural
history
gliomas.
Patients
with
newly
diagnosed
high-grade
gliomas
who
underwent
surgery
between
January
2019
June
2024
were
analyzed.
series
was
analyzed
according
classification
Berger-Sanai
Yaşargil.
Karnofsky
performance
score
(KPS),
extent
resection
(EOR),
progression-free
survival
(PFS),
overall
(OS)
considered
outcome
measures.
A
total
58
primary
glioma
patients
enrolled
study.
IDH
mutation
found
13/58
(22.4%);
specifically,
3/13
(23.1%)
grade
4,
10/13
(76.9%)
3.
Furthermore,
40/58
(69%)
gross
(GTR),
15
(26%)
subtotal
resection,
3
(5%)
partial
resection.
Middle
cerebral
artery
encasement
negatively
affected
OS.
GTR,
radiotherapy,
KPS,
autonomous
deambulation
at
month
after
positively
used
11
47
cases,
respectively.
comparison
different
did
display
differences
neurological
deficits
OS
(p
>
0.05).
related
greater
achievement
GTR
=
0.031).
According
classification,
has
higher
EOR
postoperative
KPS
when
lesion
zone
III-IV
0.029).
Greater
can
be
achieved
an
acceptable
morbidity
profile
predictive
improved
Both
corridors
insula
associated
low
profiles.
intraoperative
mapping
more
favorable
for
achieving
EOR,
particularly
inferior
border
Sylvian
fissure.
Language: Английский
Double Fluorescence-Guided Surgery With 5-ALA And Sodium Fluorescein In Grade 2 And Grade 3 adult-type diffuse Gliomas: Retrospective Analysis of 112 cases
Andrea Bianconi,
No information about this author
Marta Bonada,
No information about this author
Pietro Zeppa
No information about this author
et al.
Brain and Spine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 104277 - 104277
Published: May 1, 2025
Language: Английский
Agents for Fluorescence-Guided Glioblastoma Surgery
E. Roméo,
No information about this author
Andreas G. Tzakos,
No information about this author
Timothy Crook
No information about this author
et al.
Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(5), P. 637 - 637
Published: May 11, 2025
Glioblastoma
(GBM)
is
the
most
aggressive
primary
brain
tumor,
characterized
by
rapid
progression
and
a
median
survival
of
no
more
than
12–18
months.
Fluorescence-guided
surgery
crucial,
as
it
allows
for
tumor
visualization
aids
in
its
complete
removal,
which
essential
improving
rates.
We
conducted
literature
review
to
identify
fluorescent
agents
that
have
been
utilized
removal
GBM
assess
their
benefits
achieving
maximum
resection.
Our
analysis
focuses
on
advantages,
limitations,
potential
impact
surgical
precision
patient
outcomes.
searched
PubMed
database
studies
published
fluorescence-guided
resection
evaluated
utility
each
agent
terms
outcomes,
gross
total
(GTR),
sensitivity
specificity
tumor.
The
revealed
three
successfully
are
5-aminolevulinic
acid
(5-ALA),
sodium
fluorescein,
indocyanine
green.
In
addition
these,
variety
dyes
investigated
studies,
including
peptides,
lipids,
nanosystems,
appear
be
very
promising.
To
date,
numerous
proposed
GBM.
However,
(5-ALA)
remains
only
widely
adopted
clinical
practice,
safety
efficacy
well-established.
Further
trials
necessary
utility,
effectiveness,
advantages
emerging
enhancing
Language: Английский
“Beyond the Knife”—Applying Theranostic Technologies to Enhance Outcomes in Neurosurgical Oncology
Santosh Guru,
No information about this author
Fred C. Lam,
No information about this author
Amirhossein Akhavan-Sigari
No information about this author
et al.
Brain Sciences,
Journal Year:
2024,
Volume and Issue:
14(12), P. 1253 - 1253
Published: Dec. 13, 2024
The
current
standard
of
care
for
brain
tumor
management
includes
maximal
safe
surgical
resection
followed
by
concurrent
chemotherapy
and
radiation
therapy.
Recent
advances
in
image-guided
techniques
have
enhanced
the
precision
resections,
yet
there
remains
a
critical
need
innovative
technologies
to
further
improve
patient
outcomes.
Techniques
such
as
fluorescence
neurosurgery
combination
with
stereotactic
radiosurgery
improved
outcomes
patients
tumors.
In
this
article
Brain
Science’s
Special
Issue
Advances
Translational
Neuro-Oncology,
we
review
use
treatment
addition,
summarize
emerging
theranostic
nanoparticles
delivery
diagnostic
therapeutic
enable
neurosurgeon
perform
more
precise
resections
operating
room,
specifically
target
existing
novel
treatments
cells,
augment
efficacy
radiosurgery.
These
translational
tools
will
allow
neurosurgeons,
neuro-oncologists,
oncologists
go
“beyond
knife”
survival
patients.
Language: Английский